1-4 of 4
Mengkun Zhang
Close
Sort by
Journal Articles

The Syk Inhibitor TAK-659 Prevents Splenomegaly and Tumor Development in a Murine Model of EBV-Associated Lymphoma

Osman Cen, PhD, Karuppiah Kannan, PhD, Jessica J. Huck, M.A., Jie Yu, M.S., Mengkun Zhang, MD, Leo I Gordon, MD, Richard Longnecker, PhD
Journal: Blood
Blood (2016) 128 (22): 4179.
https://doi.org/10.1182/blood.V128.22.4179.4179
Published: 2016
Journal Articles

The Investigational Aurora A Kinase Inhibitor MLN8237 in Combination with Vincristine Demonstrates Robust Anti-Tumor Activity in Preclinical B-Cell Non-Hodgkin's Lymphoma Models

Mengkun Zhang, Jessica Huck, Marc Hyer, Karuppian Kannan, Wen Chyi Shyu, Susan Chen, Mark Manfredi, Jeffrey Ecsedy
Journal: Blood
Blood (2011) 118 (21): 2733.
https://doi.org/10.1182/blood.V118.21.2733.2733
Published: 2011
Journal Articles

Anti-Tumor Activity of the Aurora a Inhibitor MLN8237 in Diffuse Large B-Cell Lymphoma Preclinical Models.

Jessica J Huck, BA, Mengkun Zhang, MD, Marc L Hyer, PhD, Mark G Manfredi, PhD
Journal: Blood
Blood (2008) 112 (11): 1592.
https://doi.org/10.1182/blood.V112.11.1592.1592
Published: 2008
Journal Articles

Overlapping Functions of E- and P-Selectin in Neutrophil Recruitment During Acute Inflammation

Jonathon W. Homeister, Mengkun Zhang, Paul S. Frenette, Richard O. Hynes, Denisa D. Wagner, John B. Lowe, Rory M. Marks
Journal: Blood
Blood (1998) 92 (7): 2345–2352.
https://doi.org/10.1182/blood.V92.7.2345
Published: 1998